These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12711580)

  • 21. What's the difference between a pacemaker and an implantable cardioverter defibrillator (ICD)?
    Johns Hopkins Med Lett Health After 50; 2001 Nov; 13(9):8. PubMed ID: 11682906
    [No Abstract]   [Full Text] [Related]  

  • 22. Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure.
    Stevenson LW; Desai AS
    J Card Fail; 2006 Aug; 12(6):407-12. PubMed ID: 16911905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
    van Gelder IC; Smit MD; Nieuwland W; van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2238-44. PubMed ID: 17076357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of infected pacemakers and implantable cardioverter-defibrillators.
    Sohail MR
    Intern Med J; 2007 Jul; 37(7):509-10; author reply 510. PubMed ID: 17547736
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-determinable defibrillation threshold and inefficacy of implantable cardioverter/defibrillator shocks due to defective connections of the defibrillator lead terminals in the device header port.
    Maagh P; Trappe HJ; Meissner A
    Europace; 2007 Dec; 9(12):1161-2. PubMed ID: 17913694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severely malfunctioning defibrillator with cardiac resynchronization therapy showing no abnormalities during testing with the programming head in place.
    Bjerregaard P; Brown T
    Europace; 2009 Aug; 11(8):1112-4. PubMed ID: 19435737
    [No Abstract]   [Full Text] [Related]  

  • 27. Implantable cardioverter-defibrillator therapy in clinical practice.
    Cesario DA; Dec GW
    J Am Coll Cardiol; 2006 Apr; 47(8):1507-17. PubMed ID: 16630984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Difficult AV optimization in a patient with a biventricular implantable cardioverter defibrillator].
    Israel CW; Ehrlich JR; Britten M
    Herzschrittmacherther Elektrophysiol; 2006 Sep; 17(3):174-9. PubMed ID: 16969731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 31. [Association of biventricular resynchronizer and implantable cardioverter defibrillator].
    Robledo Nolasco R; Ruiz Soto JC; Méndez Espinoza F; Trujillo Cortés R; Blanco Canto M
    Arch Cardiol Mex; 2005; 75 Suppl 3():S3-89-95. PubMed ID: 16366173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrical injury during "hands on" defibrillation-A potential risk of internal cardioverter defibrillators?
    Stockwell B; Bellis G; Morton G; Chung K; Merton WL; Andrews N; Smith GB
    Resuscitation; 2009 Jul; 80(7):832-4. PubMed ID: 19446388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Electromagnetic effects of pacemaker-systems and the problem of the year 2000].
    Ohm OJ; Faerestrand S
    Tidsskr Nor Laegeforen; 1999 Nov; 119(29):4300. PubMed ID: 10667123
    [No Abstract]   [Full Text] [Related]  

  • 34. Indications for an implantable cardioverter defibrillator.
    Med Lett Drugs Ther; 2002 Nov; 44(1144):99-100. PubMed ID: 12451361
    [No Abstract]   [Full Text] [Related]  

  • 35. Unresolved issues in implantable cardioverter-defibrillator therapy.
    Mason PK; DiMarco JP
    Cardiol Clin; 2008 Aug; 26(3):433-9, vii. PubMed ID: 18538189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Annual report 2019 of the German pacemaker and defibrillator registry-part 2: implantable cardioverter-defibrillators (ICD) : Working group on cardiac pacemakers and cardioverter-defibrillators at IQTIG-Institute for Quality Assurance and Transparency in Healthcare].
    Markewitz A;
    Herzschrittmacherther Elektrophysiol; 2021 Dec; 32(4):524-540. PubMed ID: 34328535
    [No Abstract]   [Full Text] [Related]  

  • 37. Setting standards for pacemaker and ICD lead extraction.
    Harv Heart Lett; 2009 Nov; 20(3):6. PubMed ID: 20614641
    [No Abstract]   [Full Text] [Related]  

  • 38. [Latest results of treatment with pacemaker and implantable cardioverter defibrillators].
    Merkely B
    Orv Hetil; 2005 May; 146(20 Suppl 2):1088-98. PubMed ID: 15945237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inappropriate defibrillator discharges caused by an unusual interaction between an implantable cardioverter defibrillator and a pacemaker.
    Liao PC; Lai LP; Lin JL; Huang SK
    J Cardiovasc Electrophysiol; 2002 Nov; 13(11):1178-9. PubMed ID: 12475114
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.
    Ermis C; Seutter R; Zhu AX; Benditt LC; VanHeel L; Sakaguchi S; Lurie KG; Lu F; Benditt DG
    J Am Coll Cardiol; 2005 Dec; 46(12):2258-63. PubMed ID: 16360055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.